← Leaderboards
Matthew J. Flick
Cincinnati Childrens Hosp Med Ctr
$9,178,399
Attributed
$18,069,747
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,069,747 · 11
By mechanism
R01$9,451,749 · 6
U01$7,948,245 · 2
P30$616,753 · 1
R13$53,000 · 2
Top collaborators
- Melissa L Fishel10 shared
- Bumsoo Han10 shared
- Alisa S Wolberg9 shared
- Lisa Gralinski4 shared
- Stephen F Konieczny3 shared
- Christian Kastrup2 shared
- Punam Malik2 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Eric S Mullins$2,717,195
- Edith M Janssen$2,952,624
- Vivian Hwa$2,125,267
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingProgramsCoagulation ProcessFibrinLinkMutationTissuesBlood CoagulationDepositionThrombinFibrinogenIn VivoInflammatoryMolecularMortalityAutomobile DrivingBaseMalignant NeoplasmsPathogenesisCessation Of LifeReagentInflammationPeptide HydrolasesFostering
Grant awards (40)
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$932,376
U01 · FY2025 · CA
Novel mechanisms to limit thrombosis by decreasing fibrinogen or suppressing fibrin matrix formation$720,242
R01 · FY2025 · HL · contact PI
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$885,794
U01 · FY2024 · CA
Novel mechanisms to limit thrombosis by decreasing fibrinogen or suppressing fibrin matrix formation$734,117
R01 · FY2024 · HL · contact PI
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19$531,940
R01 · FY2024 · HL · contact PI
11th Symposium on Hemostasis at University of North Carolina at Chapel Hill$30,000
R13 · FY2024 · HL · contact PI
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$670,662
U01 · FY2023 · CA
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19$542,806
R01 · FY2023 · HL · contact PI
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$257,378
U01 · FY2023 · CA
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment$956,721
U01 · FY2022 · CA
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$834,158
U01 · FY2022 · HL · contact PI
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19$551,675
R01 · FY2022 · HL · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$403,147
R01 · FY2022 · CA · contact PI
Fibrin(ogen) control of metabolic inflammation and obesity$371,618
R01 · FY2022 · DK · contact PI
2022 Plasminogen Activation and Extracellular Proteolysis Gordon Research Conference and Seminar$23,000
R13 · FY2022 · HL · contact PI
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$844,766
U01 · FY2021 · HL · contact PI
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19$580,295
R01 · FY2021 · HL · contact PI
Fibrin(ogen) control of metabolic inflammation and obesity$372,318
R01 · FY2021 · DK · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$5,030
R01 · FY2021 · CA · contact PI
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$855,078
U01 · FY2020 · HL · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$459,478
R01 · FY2020 · CA · contact PI
Fibrin(ogen) control of metabolic inflammation and obesity$376,526
R01 · FY2020 · DK · contact PI
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$892,860
U01 · FY2019 · HL · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$473,443
R01 · FY2019 · CA · contact PI
Fibrin(ogen) control of metabolic inflammation and obesity$404,907
R01 · FY2019 · DK · contact PI
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis$818,452
U01 · FY2018 · HL · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$417,066
R01 · FY2018 · CA · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$431,066
R01 · FY2017 · CA · contact PI
Hemostatic factors and sickle cell disease$382,500
R01 · FY2016 · HL
Hemostatic factors and sickle cell disease$376,762
R01 · FY2015 · HL
Core 2 - Animal Models of Inflammatory Disease Core$124,369
P30 · FY2015 · AR · contact PI
Core 2 - Animal Models of Inflammatory Disease Core$126,018
P30 · FY2014 · AR · contact PI
Mechanisms linking the hemostatic protease thrombin to arthritic disease$248,653
R01 · FY2013 · AR · contact PI
Core 2 - Animal Models of Inflammatory Disease Core$121,223
P30 · FY2013 · AR · contact PI
Mechanisms linking the hemostatic protease thrombin to arthritic disease$261,740
R01 · FY2012 · AR · contact PI
Core 2 - Animal Models of Inflammatory Disease Core$123,438
P30 · FY2012 · AR · contact PI
Mechanisms linking the hemostatic protease thrombin to arthritic disease$261,740
R01 · FY2011 · AR · contact PI
Core 2 - Animal Models of Inflammatory Disease Core$121,705
P30 · FY2011 · AR · contact PI
Mechanisms linking the hemostatic protease thrombin to arthritic disease$271,830
R01 · FY2010 · AR · contact PI
Mechanisms linking the hemostatic protease thrombin to arthritic disease$272,850
R01 · FY2009 · AR · contact PI